» Articles » PMID: 37138218

Functional Role and Epithelial to Mesenchymal Transition of the MiR-590-3p/MDM2 Axis in Hepatocellular Carcinoma

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2023 May 3
PMID 37138218
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is considerable evidence that microRNAs (miRNAs) regulate several key tumor-associated genes/pathways and may themselves have a dual regulatory function either as tumor suppressors or oncogenic miRNA, depending on the tumor type. MicroRNA-590-3p (miR-590-3p) is a small non-coding RNA involved in the initiation and progression of numerous tumors. However, its expression pattern and biological role in hepatocellular carcinoma (HCC) are controversial.

Results: In the current work, computational and RT-qPCR analysis revealed that HCC tissues and cell lines exhibited miR-590-3p downregulation. Forced expression of miR-590-3p attenuated HepG2 cells proliferation, migration, and repressed EMT-related gene expression. Bioinformatic, RT-qPCR, and luciferase assays revealed that MDM2 is a direct functional target of miR-590-3p. Moreover, the knockdown of MDM2 mimicked the inhibitory effect of miR-590-3p in HepG2 cells.

Conclusion: We have identified not only novel targets for miR-590-3p in HCC, but also novel target genes for miR590-3p/MDM2 pathway in HCC like SNAIL, SLUG, ZEB1, ZEB2, and N-cadherin. Furthermore, these findings demonstrate a crucial role for MDM2 in the regulatory mechanism of EMT in HCC.

Citing Articles

Circulating MicroRNAs in Idiopathic Pulmonary Fibrosis: A Narrative Review.

Colin Waldo M, Quintero-Millan X, Negrete-Garcia M, Ruiz V, Sommer B, Romero-Rodriguez D Curr Issues Mol Biol. 2024; 46(12):13746-13766.

PMID: 39727949 PMC: 11674445. DOI: 10.3390/cimb46120821.


-Regulated Signaling Pathways in Breast Cancer Progression.

Capela A, Tavares-Marcos C, Estima-Arede H, Nobrega-Pereira S, de Jesus B Cancers (Basel). 2024; 16(3).

PMID: 38339387 PMC: 10854850. DOI: 10.3390/cancers16030636.

References
1.
Suresh D, Srinivas A, Kumar D . Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease. Front Oncol. 2020; 10:601710. PMC: 7734960. DOI: 10.3389/fonc.2020.601710. View

2.
Shaikh M, Morano W, Lee J, Gleeson E, Babcock B, Michl J . Emerging Role of MDM2 as Target for Anti-Cancer Therapy: A Review. Ann Clin Lab Sci. 2016; 46(6):627-634. View

3.
Kishore S, Jaskiewicz L, Burger L, Hausser J, Khorshid M, Zavolan M . A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nat Methods. 2011; 8(7):559-64. DOI: 10.1038/nmeth.1608. View

4.
Chen X, Qiu J, Yang D, Lu J, Yan C, Zha X . MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9. PLoS One. 2013; 8(11):e78794. PMC: 3827260. DOI: 10.1371/journal.pone.0078794. View

5.
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T . Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012; 9(7):676-82. PMC: 3855844. DOI: 10.1038/nmeth.2019. View